Loss of RARRES3 is considered a key driver of lung metastasis in estrogen receptor-negative (ER-) breast cancer, which disables cellular differentiation and engages in metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma [44]. Here, PLAAT4 is linked to breast carcinoma.